Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: Anti-inflammatory and antioxidant activity

Journal of Neurochemistry

Volumn 107, Issue 1, 2008, Pages 230-240

  Valsecchi, Anna Elisa ^a   Franchi, Silvia ^a   Panerai, Alberto Emilio ^a   Sacerdote, Paola ^a   Trovato, Anna Elisa ^a   Colleoni, Mariapia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic constriction injury; Estrogen receptor ; Genistein; Mouse; Neuropathic pain; Soy phytoestrogen

Indexed keywords

CATALASE; CYTOKINE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; PHYTOESTROGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; MALE; MOUSE; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD; SPINAL GANGLION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; GENISTEIN; HYPERALGESIA; INFLAMMATION; INFLAMMATION MEDIATORS; LIGATION; MALE; MICE; MICE, INBRED C57BL; NEURONS, AFFERENT; NOCICEPTORS; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYTOESTROGENS; PLANT EXTRACTS; RECEPTORS, ESTROGEN; SCIATIC NEUROPATHY; SOYBEANS; TREATMENT OUTCOME;

MUS;

EID: 51849101592     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05614.x     Document Type: Article

References (40)

1. An J., Tzagarakis-Foster C., Scharschmidt T. C., Lomri N. Leitman D. C. (2001) Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 276, 17808 17814.
2. Bennett G. J. Xie Y. K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87 107.
3. Bianco N. R., Chaplin L. J. Montano M. M. (2005) Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. Biochem. J. 385, 279 287.
4. Bjorling D. E. Wang Z-Y. (2001) Estrogen and neuroinflammation. Urology 57 (Suppl. 6A 40 46.
5. Campbell J. N. Meyer R. A. (2006) Mechanisms of neuropathic pain. Neuron 52, 77 92.
6. Carrillo M. C., Kanai S., Ivy G. O. Kitani K. (1992) Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats. Biochem. Pharmacol. 44, 2185 2189.
7. Clatworthy A. L., Illich P. A., Castro G. A. Walters E. T. (1995) Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184, 5 8.
8. Compton D. R., Sheng S., Carlson K. E., Rebacz N. A., Lee I. Y., Katzenellenbogen B. S. Katzenellenbogen J. A. (2004) Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen beta antagonist activity. J. Med. Chem. 47, 5872 5893.
9. Costa B., Trovato A. E., Comelli F., Giagnoni G. Colleoni M. (2007) The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharmacol. 556, 75 83.
10. Currie L. J., Harrison M. B., Trugman J. M., Bennett J. P. Wooten J. F. (2004) Postmenopausal estrogen use affects risk for Parkinson disease. Arch. Neurol. 61, 886 888.
11. Davis A. M., Ellersieck M. R., Grimm K. M. Rosenfeld C. S. (2006) The effects of the selective estrogen receptor modulators, methyl-piperidino- pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Mol. Reprod. Dev. 73, 1034 1044.
12. Duffy C., Perez K. Partridge A. (2007) Implications of phytoestrogen intake for breast cancer. CA Cancer J. Clin. 57, 260 277.
13. Dugas A. J., Castaneda-Acosta J., Bonin G. C., Price K. L., Fisher N. H. Winston G. W. (2000) Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships. J. Nat. Prod. 63, 327 331.
14. Groyer G., Eychenne B., Girard C., Rajkowski K., Schumacher M. Cadepond F. (2006) Expression and functional state of the corticosteroid receptors and 11β-hydroxysteroid dehydrogenase type 2 in Schwann cells. Endocrinology 147, 4339 4350.
15. Howell A., Osborn C. K., Morris C. Wakeling A. E. (2000) ICI 182,780 (Faslodex™). Development of a novel, "pure" antiestrogen. Cancer 89, 817 825.
16. Kim H. K., Park S. K., Zhou J. L., Taglialatela G., Chung K., Coggeshall R. E. Chung J. M. (2004) Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 111, 116 124.
17. Kuiper G. G. J. M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S. Gustafsson J-A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863 870.
18. Leventhal L., Brandt M. R., Cummons T. A., Piesla M. J., Rogers K. E. Harris H. A. (2006) An estrogen receptor-β agonist is active in models of inflammatory and chemical-induced pain. Eur. J. Pharmacol. 553, 146 148.
19. Lewis D. K., Johnson A. B., Stohlgren S., Harms A. Sohrabji F. (2008) Effects of estrogen receptor antagonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J. Neuroimmunol. 195, 47 59.
20. Liu X., Fan X. L., Zhao Y., Luo G. R., Li X. P., Li R. Le W. D. (2005) Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. J. Neurosci. Res. 81, 653 665.
21. Liu L. X., Chen W. F., Xie J. X. Wong M. S. (2008) Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Neurosci. Res. 60, 156 161.
22. Martucci C., Trovato A. E., Costa B. et al. (2008) The purinergic antagonist PPADS reduces pain related behaviors and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 137, 81 95.
23. McCarty M. F. (2006) Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med. Hypoth. 67, 251 269.
24. McClain R. M., Wolz E., Davidovich A., Edwards J. Bausch J. (2007) Reproductive safety studies with genistein in rats. Food Chem. Toxicol. 45, 1319 1332.
25. Mor G., Nilsen J., Horvath T., Bechmann I., Brown S., Garcia-Segura L. M. Naftolin F. (1999) Estrogen and microglia: a regulatory system that affects the brain. J. Neurobiol. 40, 484 496.
26. Myers R. R., Campana W. M. Shubayev V. I. (2006) The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today 11, 8 20.
27. Naik A. K., Tandan S. K., Dudhgaonkar S. P., Jadhav S. H., Kataria M., Prakash V. R. Kumar D. (2006) Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur. J. Pain 10, 573 579.
28. Sawada H. Shimohama S. (2003) Estrogens and Parkinson disease: novel approach for neuroprotection. Endocrine 21, 77 79.
29. Scholz J. Woolf C. J. (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361 1368.
30. Sharma S., Kulkarni S. K. Chopra K. (2007) Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam. Clin. Pharmacol. 21, 89 94.
31. Shir Y., Campbell J. N., Raja S. N. Seltzer Z. (2002) The correlation between dietary soy phytoestrogens and neuropathic pain behavior in rats after partial denervation. Anesth. Analg. 94, 421 426.
32. Siow R. C. M., Li F. Y. L., Rowlands D. J., de Winter P. Mann G. E. (2007) Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med. 42, 909 925.
33. Straub R. H. (2007) The complex role of estrogens in inflammation. Endocr. Rev. 28, 521 574.
34. Sun J., Huang Y. R., Harrington W. R., Sheng S., Katzenellenbogen J. A. Katzenellenbogen B. S. (2002) Antagonists selective for estrogen receptor α. Endocrinology 143, 941 947.
35. Verdrengh M., Jonsson I. M., Holmdahl R. Tarkowski A. (2003) Genistein as an anti-inflammatory agent. Inflamm. Res. 52, 341 346.
36. Vina J., Gomez-Cabrera M. C. Borràs C. (2007a) Fostering antioxidant defences: up-regulation of antioxidant genes or antioxidant supplementation. Br. J. Nutr. 98 (Suppl. 1 S36 S40.
37. Vina J., Lloret A., Vallés S. L., Borràs C., Badia M-C., Pallardò F. V., Sastre J. Alonso M-D. (2007b) Effect of gender on mitochondrial toxicity of Alzheimer's Aβ peptide. Antioxid. Redox Signal. 9, 1677 1690.
38. Wakeling A. E. Bowler J. (1987) Steroidal pure antioestrogens. Endocrinology 112, R7 R10.
39. Zamek-Gliszczynski M. J., Xiong H., Patel N. J., Turncliff R. Z., Pollack G. M. Brouwer K. L. R. (2003) Pharmacokinetics of 5(and 6)-carboxi-2′, 7′-dichlorofluorescein and its diacetate promoiety in the liver. J. Pharmacol. Exp. Ther. 304, 801 809.
40. Zimmermann M. (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109 110.